<p num="1"><br/><br/><br/>Mesenchymal stem cells which express TNF-.alpha. receptor Type I in an amount <br/>of at least 13 pg/106 cells. Such mesenchymal stem cells inhibit the <br/>proliferation of lymphocytes and may be employed, in particular, in the <br/>treatment of graft-versus-host disease.<br/></p>
申请公布号
CA2635915(A1)
申请公布日期
2007.08.02
申请号
CA20072635915
申请日期
2007.01.05
申请人
OSIRIS THERAPEUTICS, INC.
发明人
MARCELINO, MICHELLE;BUBNIC, SIMON;MONROY, RODNEY;TYRELL, ALICIA;CARTER, DIANE;DANILKOVITCH, ALLA
